Prevalence and Antibiotic Resistance Patterns of Uropathogenic Escherichia coli Isolated from Community-Acquired Urinary Tract Infections: A Cross-Sectional Study
Abstract
Background: Escherichia coli is the main cause of urinary tract infections (UTIs), which are among the most common community-acquired diseases in the world. Particularly in low- and middle-income nations, the growing antibiotic resistance in uropathogenic E. coli (UPEC) has become a serious therapeutic issue.
Objective: To determine the prevalence and antibiotic resistance patterns of UPEC isolated from community-acquired UTIs in Pakistan.
Methods: From March 2024 to April 2025, this cross-sectional descriptive research was conducted in tertiary care facilities across Pakistan. 110 midstream urine samples from people with UTI symptoms were collected in total. UPEC was grown and identified using standard microbiological techniques, and the Kirby-Bauer disk diffusion method was used to test for antibiotic susceptibility in compliance with CLSI 2023 criteria. Resistance to at least three antibiotic classes was referred to as multidrug resistance (MDR). SPSS version 25 was utilized to analyze the data.
Results: UPEC was isolated in 68 of 110 urine samples, yielding a prevalence of 61.8%. The majority of cases occurred in females (72.1%), particularly in the 18–40 years age group (55.9%). Resistance was highest against ampicillin (85.3%), trimethoprim–sulfamethoxazole (73.5%), ciprofloxacin (66.2%), and levofloxacin (61.8%). Moderate resistance was noted to ceftriaxone (50.0%) and cefotaxime (48.5%), whereas aminoglycosides retained better activity, with gentamicin (39.7%) and…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.